Has Satish Rao, MD received payments from drug or device companies?

Yes. Drug and device makers reported $335,034 in general payments to Satish Rao, MD across 229 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Satish Rao, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Satish Rao, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Satish Rao, MD

Gastroenterology · Augusta, GANPI 1063485340

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $256,355 of the $335,034 with a category attached, or 76.5%. 17 manufacturers reported payments, led by Ardelyx, Inc. at 46.2% of the total. 2025 is the largest year on record at $118,296, more than ten times the $1,328 reported in 2019. Among gastroenterology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$335,034in general payments, 2019–2025

Across 229 payments — averaging $1463.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Ardelyx, Inc.$155K
Vibrant Gastro, Inc.$116K
Dr.reddy's Laboratories,inc.$33K
Sanofi-aventis U.S. LLC$17K
AbbVie$6K
Takeda Pharmaceuticals U.S.A., Inc.$4K
plus $5K from 11 others

$70,975in research payments, 2019–2025

Across 5 payments — averaging $14,195 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Laborie Medical Technologies Corp.$61K
Bausch Health US, LLC$9K
Takeda Pharmaceuticals U.S.A., Inc.$638

What the payments were for

Consulting fees$256,35577%
Speaking & faculty fees$53,73016%
Travel & lodging$18,2245%
Food & beverage$3,3511%
Education$3,3751%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Ardelyx, Inc.	104	$154,660
Vibrant Gastro, Inc.	95	$115,581
Dr.reddy's Laboratories,inc.	4	$32,930
Sanofi-aventis U.S. LLC	2	$16,817
AbbVie(2 entities)	2	$5,550
Takeda Pharmaceuticals U.S.A., Inc.	2	$4,028
Mylan Inc.	1	$2,500
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	7	$1,620
Palette Life Sciences, Inc.	1	$600
Enterra Medical, Inc.	2	$191
Phathom Pharmaceuticals, Inc.	1	$183
Livanova USA, Inc.	1	$132
Medtronic	2	$112
QOL Medical, LLC	2	$57
GI Supply, Inc.	1	$31
Celltrion USA Inc.	1	$22
Pfizer	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

IBSRELA$150,924
Vibrant Starter Kit$115,581
Amitiza$4,028
XIFAXAN$1,466
VIBERZI$1,050
Solesta$600
VOQUEZNA$183
VNS Therapy Symmetry Model 8103 Generator$132
TRULANCE$117

How this compares

$335,034 in reported general payments places this provider in the 95th percentile of 492 gastroenterology providers in Georgia.

See all gastroenterology providers in Georgia →

Medicare billing

Part B allowed, 2024

$25,714

Medicare patients

130

Services billed

439

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl	11	$202

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Augusta

Bryan CurtinAugusta$82K
Kenneth VegaAugusta$59K
Sunil LalAugusta$26K
Nitin GuptaAtlanta$1.1M
Cynthia RudertAtlanta$720K
Douglas WolfAtlanta$668K
Kavita KongaraAtlanta$492K
Girish AnandAtlanta$425K
Roshan ShresthaAtlanta$317K
Hetal KarsanAtlanta$314K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →